SCN1A and epilepsy: Therefore, mutations in SCN1A and SCN8A both present clinically with epilepsy but probably have an opposite working mechanism (loss-of-function mutation leading to loss of inhibition, and gain-of-function mutation leading to increased excitability of excitatory neurons, respectively), both leading to increased excitability.